advertisement

Topcon

Daka Q 9

Showing records 1 to 9 | Display all abstracts from Daka Q

117529 Retinal Ganglion Cell Function and Perfusion following Intraocular Pressure Reduction with Preservative-Free Latanoprost in Patients with Glaucoma and Ocular Hypertension
Daka Q
Journal of clinical medicine 2024; 13:
118235 Metformin in Glaucoma Treatment
Daka Q
Journal of Glaucoma 2024; 33: 387-393
117529 Retinal Ganglion Cell Function and Perfusion following Intraocular Pressure Reduction with Preservative-Free Latanoprost in Patients with Glaucoma and Ocular Hypertension
Sustar Habjan M
Journal of clinical medicine 2024; 13:
118235 Metformin in Glaucoma Treatment
Neziri B
Journal of Glaucoma 2024; 33: 387-393
117529 Retinal Ganglion Cell Function and Perfusion following Intraocular Pressure Reduction with Preservative-Free Latanoprost in Patients with Glaucoma and Ocular Hypertension
Sustar Habjan M; Meglič A
Journal of clinical medicine 2024; 13:
118235 Metformin in Glaucoma Treatment
Lindner E
Journal of Glaucoma 2024; 33: 387-393
117529 Retinal Ganglion Cell Function and Perfusion following Intraocular Pressure Reduction with Preservative-Free Latanoprost in Patients with Glaucoma and Ocular Hypertension
Perovšek D
Journal of clinical medicine 2024; 13:
118235 Metformin in Glaucoma Treatment
Azuara Blanco A
Journal of Glaucoma 2024; 33: 387-393
117529 Retinal Ganglion Cell Function and Perfusion following Intraocular Pressure Reduction with Preservative-Free Latanoprost in Patients with Glaucoma and Ocular Hypertension
Atanasovska Velkovska M; Cvenkel B
Journal of clinical medicine 2024; 13:

Issue 24-4

Change Issue


advertisement

WGA Rescources